Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-074511
Filing Date
2025-08-06
Accepted
2025-08-06 07:15:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2522638d1_424b5.htm 424B5 7930
2 GRAPHIC tm2522638d1_424b5img01.jpg GRAPHIC 4590
  Complete submission text file 0001104659-25-074511.txt   15403
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)